Intestinal ultrasound to monitor ulcerative colitis and Crohn's disease has become the standard of care in Canada and many parts of Europe, but has never gained a foothold in the United States. A new Mount Sinai program aims to change that.
Mount Sinai has burnished its reputation as a leading inflammatory bowel disease (IBD) center by deploying one of the nation’s first intestinal ultrasound machines for fast, accurate, and noninvasive assessment of ulcerative colitis (UC) and Crohn’s disease. The advanced procedure presages a new era for IBD patients who now have a way to visualize with their physicians during clinic visits the progress of their treatment, and whether changes are necessary.
